Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Uterine leiomyoma
ADR ID BADD_A04482
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.04      Reproductive neoplasms female benign
16.04.02      Uterine neoplasms benign
16.04.02.001      Uterine leiomyoma
21      Reproductive system and breast disorders
21.07      Uterine, pelvic and broad ligament disorders
21.07.02      Uterine neoplasms
21.07.02.004      Uterine leiomyoma
Description A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues. [MeSH]
MedDRA Code 10046798
MeSH ID D007889
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Fibroid uterine enlarged | Fibroids | Intramural leiomyoma of uterus | Leiomyoma of uterus, unspecified | Leiomyomauterine increase | Submucous leiomyoma of uterus | Subserous leiomyoma of uterus | Uterine fibroid | Uterine fibroids | Uterine fibroids enlarged | Uterine fibromyoma | Uterine leiomyoma | Uterine myoma | Uterine fibroids aggravated | Hysteromyoma | Uterine fibromatosis | Metrofibroma | Uterine myomatosis | Uterine fibroma | Leiomyoma | Leiomyomas | Fibroid Tumor | Fibroid Tumors | Tumor, Fibroid | Tumors, Fibroid | Fibromyoma | Fibromyomas | Fibroid | Fibroid Uterus | Uterus, Fibroid | Fibroma, Uterine | Fibromas, Uterine | Uterine Fibroma | Uterine Fibromas | Fibroids, Uterine | Fibroid, Uterine | Uterine Fibroid | Uterine Fibroids | Leiomyoma, Uterine
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02111Tamoxifen--
BADD_D02112Tamoxifen citrate--
BADD_D02165Teriflunomide0.000482%
BADD_D02230Tizanidine--
BADD_D02231Tizanidine hydrochloride--
BADD_D02236Tofacitinib--
BADD_D02254Tramadol--
BADD_D02261Tranexamic acid0.003117%
BADD_D02268Treprostinil0.000222%
BADD_D02299Trisequens--
BADD_D02312Ulipristal0.000360%
BADD_D02344Vemurafenib0.000381%
BADD_D02375Water--
BADD_D02393Zolmitriptan--
BADD_D02407Upadacitinib0.000241%
BADD_D02412Octreotide--
BADD_D02464Fingolimod0.003520%
BADD_D02473Sodium chloride--
BADD_D02496Elagolix0.001136%
BADD_D02619Dienogest--
The 3th Page    First    Pre   3    Total 3 Pages